↓ Skip to main content

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia

Overview of attention for article published in Frontiers in oncology, October 2022
Altmetric Badge

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia
Published in
Frontiers in oncology, October 2022
DOI 10.3389/fonc.2022.1021662
Pubmed ID
Authors

Kota Yoshifuji, Koji Sasaki

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 25%
Lecturer > Senior Lecturer 1 6%
Student > Bachelor 1 6%
Student > Ph. D. Student 1 6%
Researcher 1 6%
Other 1 6%
Unknown 7 44%
Readers by discipline Count As %
Unspecified 4 25%
Medicine and Dentistry 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Immunology and Microbiology 1 6%
Nursing and Health Professions 1 6%
Other 0 0%
Unknown 7 44%